To counter these challenges, CELFULL's research team has developed a microencapsulated form of NADH. This innovative technology enhances NADH's stability, making it acid-resistant and enabling targeted release in the intestine. This breakthrough is protected by patents (Patent numbers US 11744804 B2\AU 2022313274\JP 7624554\ZL 202110819545.5\HK 40059289\KR 10-2694239).
As a leader in the mass production of high-quality NADH microcapsule powder, CELFULL is dedicated to supporting the scientific community. We provide our CELFULL Celfavor ® Microsphere raw materials and the corresponding blank material (the same ingredients and contents exclude NADH), supporting multi dose groups or long-term experimental studies to academic research groups engaged in NADH-related research. By donating these advanced materials, we aim to foster both academic advancement and industry development.